These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12219832)

  • 21. Morphological changes in degrading PLGA and P(DL)LA microspheres: implications for the design of controlled release systems.
    Viswanathan NB; Patil SS; Pandit JK; Lele AK; Kulkarni MG; Mashelkar RA
    J Microencapsul; 2001; 18(6):783-800. PubMed ID: 11695641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo release properties of brilliant blue and tumour necrosis factor-alpha (TNF-alpha) from poly(D,L-lactic-co-glycolic acid) multiphase microspheres.
    Iwata M; Nakamura Y; McGinity JW
    J Microencapsul; 1999; 16(6):777-92. PubMed ID: 10575629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films.
    Lu L; Garcia CA; Mikos AG
    J Biomed Mater Res; 1999 Aug; 46(2):236-44. PubMed ID: 10380002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral delivery of insulin loaded poly(fumaric-co-sebacic) anhydride microspheres.
    Furtado S; Abramson D; Burrill R; Olivier G; Gourd C; Bubbers E; Mathiowitz E
    Int J Pharm; 2008 Jan; 347(1-2):149-55. PubMed ID: 17707601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition.
    Park TG
    Biomaterials; 1995 Oct; 16(15):1123-30. PubMed ID: 8562787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of additives on stability of etoposide in PLGA microspheres.
    Schaefer MJ; Singh J
    Drug Dev Ind Pharm; 2001 Apr; 27(4):345-50. PubMed ID: 11411902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In situ characterization of the degradation of PLGA microspheres in hyaluronic acid hydrogels by optical coherence tomography.
    Patterson J; Stayton PS; Li X
    IEEE Trans Med Imaging; 2009 Jan; 28(1):74-81. PubMed ID: 19116190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dual-application poly (dl-lactic-co-glycolic) acid (PLGA)-chitosan composite scaffold for potential use in bone tissue engineering.
    Boukari Y; Qutachi O; Scurr DJ; Morris AP; Doughty SW; Billa N
    J Biomater Sci Polym Ed; 2017 Nov; 28(16):1966-1983. PubMed ID: 28777694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance.
    Grayson AC; Cima MJ; Langer R
    Biomaterials; 2005 May; 26(14):2137-45. PubMed ID: 15576189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for cartilage tissue engineering.
    Kang SW; Jeon O; Kim BS
    Tissue Eng; 2005; 11(3-4):438-47. PubMed ID: 15869422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bupivacaine-loaded comatrix formed by albumin microspheres included in a poly(lactide-co-glycolide) film: in vivo biocompatibility and drug release studies.
    Blanco MD; Bernardo MV; Gómez C; Muñiz E; Teijón JM
    Biomaterials; 1999 Oct; 20(20):1919-24. PubMed ID: 10514068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro stress effect on degradation and drug release behaviors of basic fibroblast growth factor--poly(lactic-co-glycolic-acid) microsphere.
    Xiong Y; Yu Z; Lang Y; Hu J; Li H; Yan Y; Tu C; Yang T; Song Y; Duan H; Pei F
    Drug Des Devel Ther; 2016; 10():431-40. PubMed ID: 26869764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels.
    Rooney GE; Knight AM; Madigan NN; Gross L; Chen B; Giraldo CV; Seo S; Nesbitt JJ; Dadsetan M; Yaszemski MJ; Windebank AJ
    Tissue Eng Part A; 2011 May; 17(9-10):1287-302. PubMed ID: 21198413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of acidic pH on PLGA microsphere degradation and release.
    Zolnik BS; Burgess DJ
    J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices.
    Hickey T; Kreutzer D; Burgess DJ; Moussy F
    Biomaterials; 2002 Apr; 23(7):1649-56. PubMed ID: 11922468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping in vivo microclimate pH distribution in exenatide-encapsulated PLGA microspheres.
    Hong JKY; Schutzman R; Olsen K; Chandrashekar A; Schwendeman SP
    J Control Release; 2022 Dec; 352():438-449. PubMed ID: 36030989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.